On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A new single-center study from the Netherlands quantifies the devastating outcomes of the diabetic foot attack: only 48.5% wound closure, 46% major amputation by 12 months, 26% one-year mortality, and 12-month amputation-free survival of just 39.7%. Time is tissue.
Diabetic foot ulcers (DFUs) are a common and severe complication of diabetes, often leading to lower extremity amputations. Traditional treatments, while varied, do not always prevent the progression of these ulcers, particularly in more advanced stages. However, a recent study published by Liu et al. offers hope through a novel surgical technique known as modified... Continue Reading →
Insightful, data-rich commentary as expected from our flowmigos Conte and O'Banion The Battle of the Limb Preservation Trials: BEST-CLI vs. BASIL-2 Two major randomized clinical trials comparing endovascular and open surgical approaches for patients with chronic limb-threatening ischemia (CLTI) - BEST-CLI and BASIL-2 - reported seemingly contradictory results recently. In the larger BEST-CLI trial, patients... Continue Reading →
Congratulations to Chang and coworkers on this effort. This makes us want to reach back to work from our team a dozen or so years ago, where we failed to really explore this fascinating area of creating, in essence, a distress signal in the bone leading to upregulation of factors that can potentially help toward... Continue Reading →
As a very interested vascular customer at the end of the vascular peninsula, I've been personally fascinated with my vascular colleagues' work in revisiting venous arterialization. To that end, about a year ago, I proposed a consortium of folks that were doing the most active thinking in the area. This included the team from Bergamo,... Continue Reading →
